Drug trafficker gets 7 years’ jail
Print Edition
A man was sentenced to seven years’ jail and fined 7,000 yuan (US$1,100) yesterday for trafficking a new type of synthetic cannabinoid, Jing’an District procurators said.
The man, surnamed Song, was found guilty of using a fake name to transport the drugs from neighboring Jiangsu Province through express parcels under the label of “files” and selling them in Shanghai through express mail and in-city express, the procurators said.
The synthetic cannabinoids were made into liquid for e-cigarettes.
Police seized five bottles of colorless, transparent liquids, totaling 28.89 grams, at Song’s temporary residence in August.
All contained the cannabinoid ADB-BUTINACA, said the procurators.
ADB-BUTINACA, normally used in research and forensic applications, has been listed as a controlled drug since July by the National Narcotics Control Committee.
China is the first country in the world to list 18 new psychoactive substances as controlled drugs. Last month, the committee released a new conversion table covering Ketamine and seven types of synthetic cannabinoids.
In the table, 1 gram of Ketamine is equivalent to 0.1 gram of heroin; a gram of seven kinds of synthetic cannabinoids are equal to between 0.2 and 5 grams of heroin.
Moving and selling these new types of drugs through delivery has become the major way of drug trafficking, according to the procurators.
“Most of the cases we have charged recently, have been trafficked through express mails,” said Zhang Zhongping, the chief of the second procuratorial department of the Jing’an District People’s Procuratorate.
“And the transactions are always carried out online, which is very hard to trace.”
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
